▶ 調査レポート

オープンアングル緑内障薬の世界市場レポート2020

• 英文タイトル:Global Open Angle Glaucoma Drugs Sales Market Report 2020

QYResearchが調査・発行した産業分析レポートです。オープンアングル緑内障薬の世界市場レポート2020 / Global Open Angle Glaucoma Drugs Sales Market Report 2020 / QY20ST-06900資料のイメージです。• レポートコード:QY20ST-06900
• 出版社/出版日:QYResearch / 2020年9月15日
※2025年版があります。お問い合わせください。

• レポート形態:英文、PDF、131ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品、医療
• 販売価格(消費税別)
  Single User¥560,000 (USD4,000)▷ お問い合わせ
  Multi User¥840,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,120,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、世界のオープンアングル緑内障薬市場について種類別(プロスタグランジン、炭酸脱水酵素阻害剤、コリン作動薬、その他)、用途別(病院薬局、オンライン薬局、小売薬局)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・オープンアングル緑内障薬市場の概要
・世界の主要地域別オープンアングル緑内障薬市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界のオープンアングル緑内障薬市場規模2015-2026:種類別(プロスタグランジン、炭酸脱水酵素阻害剤、コリン作動薬、その他)
・世界のオープンアングル緑内障薬市場規模2015-2026:用途別(病院薬局、オンライン薬局、小売薬局)
・オープンアングル緑内障薬の北米市場規模2015-2020
・オープンアングル緑内障薬のヨーロッパ市場規模2015-2020
・オープンアングル緑内障薬の中国市場規模2015-2020
・オープンアングル緑内障薬の日本市場規模2015-2020
・オープンアングル緑内障薬の東南アジア市場規模2015-2020
・オープンアングル緑内障薬のインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・オープンアングル緑内障薬の製造コスト分析
・販売チャネル、流通業者、顧客
・オープンアングル緑内障薬の市場動向・機会・課題
・調査の結論

A recently published report by QY Research titled Global Open Angle Glaucoma Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Open Angle Glaucoma Drugs market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Glaucoma is an eye disease that causes loss of vision and damage to the optic nerve. Open-angle glaucoma, also known as wide-angle glaucoma, is the most common type of glaucoma in the world. Glaucoma is characterized by increased intraocular pressure, which causes damage to the optic nerve.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Open Angle Glaucoma Drugs market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Open Angle Glaucoma Drugs industry.
Based on our recent survey, we have several different scenarios about the Open Angle Glaucoma Drugs YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Open Angle Glaucoma Drugs will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Open Angle Glaucoma Drugs market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Open Angle Glaucoma Drugs market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Open Angle Glaucoma Drugs market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Open Angle Glaucoma Drugs market. The report also includes nautical information, where it shows Open Angle Glaucoma Drugs market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Open Angle Glaucoma Drugs market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Open Angle Glaucoma Drugs market.
Geographical Analysis:
Based on region, the global Open Angle Glaucoma Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Open Angle Glaucoma Drugs market are
Merck
Allergan
Pfizer
Novartis
Bausch Health
Santen

Segment by Type
Prostaglandins
Carbonic Anhydrase Inhibitor
Cholinergic Drugs
Others
Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Open Angle Glaucoma Drugs market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Open Angle Glaucoma Drugs market.
• The market share of the global Open Angle Glaucoma Drugs market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Open Angle Glaucoma Drugs market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Open Angle Glaucoma Drugs market.

レポート目次

1 Open Angle Glaucoma Drugs Market Overview
1.1 Open Angle Glaucoma Drugs Product Scope
1.2 Open Angle Glaucoma Drugs Segment by Type
1.2.1 Global Open Angle Glaucoma Drugs Sales by Type (2020-2026)
1.2.2 Prostaglandins
1.2.3 Carbonic Anhydrase Inhibitor
1.2.4 Cholinergic Drugs
1.2.5 Others
1.3 Open Angle Glaucoma Drugs Segment by Application
1.3.1 Global Open Angle Glaucoma Drugs Sales Comparison by Application (2020-2026)
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Open Angle Glaucoma Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Open Angle Glaucoma Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Open Angle Glaucoma Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Open Angle Glaucoma Drugs Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Open Angle Glaucoma Drugs Industry Impact
1.5.1 How the Covid-19 is Affecting the Open Angle Glaucoma Drugs Industry
1.5.1.1 Open Angle Glaucoma Drugs Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Open Angle Glaucoma Drugs Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Open Angle Glaucoma Drugs Players to Combat Covid-19 Impact

2 Open Angle Glaucoma Drugs Estimate and Forecast by Region
2.1 Global Open Angle Glaucoma Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Open Angle Glaucoma Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Open Angle Glaucoma Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Open Angle Glaucoma Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Open Angle Glaucoma Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Open Angle Glaucoma Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Open Angle Glaucoma Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Open Angle Glaucoma Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Open Angle Glaucoma Drugs Estimates and Projections (2015-2026)
2.4.3 China Open Angle Glaucoma Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Open Angle Glaucoma Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Open Angle Glaucoma Drugs Estimates and Projections (2015-2026)
2.4.6 India Open Angle Glaucoma Drugs Estimates and Projections (2015-2026)
3 Global Open Angle Glaucoma Drugs Competition Landscape by Players
3.1 Global Top Open Angle Glaucoma Drugs Players by Sales (2015-2020)
3.2 Global Top Open Angle Glaucoma Drugs Players by Revenue (2015-2020)
3.3 Global Open Angle Glaucoma Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Open Angle Glaucoma Drugs as of 2019)
3.4 Global Open Angle Glaucoma Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Open Angle Glaucoma Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Open Angle Glaucoma Drugs Players (Opinion Leaders)
4 Global Open Angle Glaucoma Drugs Market Size by Type
4.1 Global Open Angle Glaucoma Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Open Angle Glaucoma Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Open Angle Glaucoma Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Open Angle Glaucoma Drugs Price by Type (2014-2020)
4.2 Global Open Angle Glaucoma Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Open Angle Glaucoma Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Open Angle Glaucoma Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Open Angle Glaucoma Drugs Price Forecast by Type (2021-2026)
5 Global Open Angle Glaucoma Drugs Market Size by Application
5.1 Global Open Angle Glaucoma Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Open Angle Glaucoma Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Open Angle Glaucoma Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Open Angle Glaucoma Drugs Price by Application (2015-2020)
5.2 Global Open Angle Glaucoma Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Open Angle Glaucoma Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Open Angle Glaucoma Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Open Angle Glaucoma Drugs Price Forecast by Application (2021-2026)

3 North America Open Angle Glaucoma Drugs Market Facts & Figures
3.2 North America Open Angle Glaucoma Drugs Sales Market Share by Company (2015-2020)
3.3 North America Open Angle Glaucoma Drugs Sales Market Share by Type (2015-2020)
3.4 North America Open Angle Glaucoma Drugs Sales Market Share by Application (2015-2020)

4 Europe Open Angle Glaucoma Drugs Market Facts & Figures
4.2 Europe Open Angle Glaucoma Drugs Sales Market Share by Company (2015-2020)
4.3 Europe Open Angle Glaucoma Drugs Sales Market Share by Type (2015-2020)
4.4 Europe Open Angle Glaucoma Drugs Sales Market Share by Application (2015-2020)

5 China Open Angle Glaucoma Drugs Market Facts & Figures
5.2 China Open Angle Glaucoma Drugs Sales Market Share by Company (2015-2020)
5.3 China Open Angle Glaucoma Drugs Sales Market Share by Type (2015-2020)
5.4 China Open Angle Glaucoma Drugs Sales Market Share by Application (2015-2020)

6 Japan Open Angle Glaucoma Drugs Market Facts & Figures
6.2 Japan Open Angle Glaucoma Drugs Sales Market Share by Company (2015-2020)
6.3 Japan Open Angle Glaucoma Drugs Sales Market Share by Type (2015-2020)
6.4 Japan Open Angle Glaucoma Drugs Sales Market Share by Application (2015-2020)

7 Southeast Asia Open Angle Glaucoma Drugs Market Facts & Figures
7.2 Southeast Asia Open Angle Glaucoma Drugs Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Open Angle Glaucoma Drugs Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Open Angle Glaucoma Drugs Sales Market Share by Application (2015-2020)

8 India Open Angle Glaucoma Drugs Market Facts & Figures
8.2 India Open Angle Glaucoma Drugs Sales Market Share by Company (2015-2020)
8.3 India Open Angle Glaucoma Drugs Sales Market Share by Type (2015-2020)
8.4 India Open Angle Glaucoma Drugs Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Open Angle Glaucoma Drugs Business
12.1 Merck
12.1.1 Merck Open Angle Glaucoma Drugs Corporation Information
12.1.2 Merck Open Angle Glaucoma Drugs Business Overview and Total Revenue
12.1.3 Merck Open Angle Glaucoma Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Merck Open Angle Glaucoma Drugs Products Offered
12.1.5 Merck Recent Development
12.2 Allergan
12.2.1 Allergan Open Angle Glaucoma Drugs Corporation Information
12.2.2 Allergan Open Angle Glaucoma Drugs Business Overview and Total Revenue
12.2.3 Allergan Open Angle Glaucoma Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Allergan Open Angle Glaucoma Drugs Products Offered
12.2.5 Allergan Recent Development
12.3 Pfizer
12.3.1 Pfizer Open Angle Glaucoma Drugs Corporation Information
12.3.2 Pfizer Open Angle Glaucoma Drugs Business Overview and Total Revenue
12.3.3 Pfizer Open Angle Glaucoma Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Pfizer Open Angle Glaucoma Drugs Products Offered
12.3.5 Pfizer Recent Development
12.4 Novartis
12.4.1 Novartis Open Angle Glaucoma Drugs Corporation Information
12.4.2 Novartis Open Angle Glaucoma Drugs Business Overview and Total Revenue
12.4.3 Novartis Open Angle Glaucoma Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Novartis Open Angle Glaucoma Drugs Products Offered
12.4.5 Novartis Recent Development
12.5 Bausch Health
12.5.1 Bausch Health Open Angle Glaucoma Drugs Corporation Information
12.5.2 Bausch Health Open Angle Glaucoma Drugs Business Overview and Total Revenue
12.5.3 Bausch Health Open Angle Glaucoma Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Bausch Health Open Angle Glaucoma Drugs Products Offered
12.5.5 Bausch Health Recent Development
12.6 Santen
12.6.1 Santen Open Angle Glaucoma Drugs Corporation Information
12.6.2 Santen Open Angle Glaucoma Drugs Business Overview and Total Revenue
12.6.3 Santen Open Angle Glaucoma Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Santen Open Angle Glaucoma Drugs Products Offered
12.6.5 Santen Recent Development

13 Open Angle Glaucoma Drugs Manufacturing Cost Analysis
13.1 Open Angle Glaucoma Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Open Angle Glaucoma Drugs
13.4 Open Angle Glaucoma Drugs Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Open Angle Glaucoma Drugs Distributors List
14.3 Open Angle Glaucoma Drugs Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Open Angle Glaucoma Drugs Sales (K Bottles) Growth Rate by Type (2020-2026)
Table 2. Global Open Angle Glaucoma Drugs Sales (K Bottles) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Open Angle Glaucoma Drugs Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Open Angle Glaucoma Drugs Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Open Angle Glaucoma Drugs Players to Combat Covid-19 Impact
Table 8. Global Market Open Angle Glaucoma Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Open Angle Glaucoma Drugs Sales (K Bottles) by Region (2015-2020)
Table 10. Global Open Angle Glaucoma Drugs Sales Market Share by Region (2015-2020)
Table 11. Global Open Angle Glaucoma Drugs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Open Angle Glaucoma Drugs Revenue Share by Region (2015-2020)
Table 13. Global Open Angle Glaucoma Drugs Sales (K Bottles) Forecast by Region (2021-2026)
Table 14. Global Open Angle Glaucoma Drugs Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Open Angle Glaucoma Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Open Angle Glaucoma Drugs Revenue Share Forecast by Region (2021-2026)
Table 17. Global Open Angle Glaucoma Drugs (K Bottles) of Key Companies (2015-2020)
Table 18. Global Open Angle Glaucoma Drugs Sales Share by Company (2015-2020)
Table 19. Global Open Angle Glaucoma Drugs Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Open Angle Glaucoma Drugs Revenue Share by Company (2015-2020)
Table 21. Global Open Angle Glaucoma Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Open Angle Glaucoma Drugs as of 2019)
Table 22. Global Open Angle Glaucoma Drugs Average Price (USD/Bottle) of Key Company (2015-2020)
Table 23. Manufacturers Open Angle Glaucoma Drugs Manufacturing Sites and Area Served
Table 24. Manufacturers Open Angle Glaucoma Drugs Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Open Angle Glaucoma Drugs Players
Table 27. Global Open Angle Glaucoma Drugs Sales (K Bottles) by Type (2015-2020)
Table 28. Global Open Angle Glaucoma Drugs Sales Share by Type (2015-2020)
Table 29. Global Open Angle Glaucoma Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Open Angle Glaucoma Drugs Price (K Bottles) by Type (2015-2020)
Table 31. Global Open Angle Glaucoma Drugs Sales Share by Type (2021-2026)
Table 32. Global Open Angle Glaucoma Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Open Angle Glaucoma Drugs Revenue Share by Type (2021-2026)
Table 34. Global Open Angle Glaucoma Drugs Price (K Bottles) by Type (2021-2026)
Table 35. Global Open Angle Glaucoma Drugs Sales (K Bottles) by Application (2015-2020)
Table 36. Global Open Angle Glaucoma Drugs Sales Share by Application (2015-2020)
Table 37. Global Open Angle Glaucoma Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Open Angle Glaucoma Drugs Price (K Bottles) by Application (2015-2020)
Table 39. Global Open Angle Glaucoma Drugs Sales (K Bottles) by Application (2021-2026)
Table 40. Global Open Angle Glaucoma Drugs Sales Share by Application (2021-2026)
Table 41. Global Open Angle Glaucoma Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Open Angle Glaucoma Drugs Revenue Share by Application (2021-2026)
Table 43. Global Open Angle Glaucoma Drugs Price (K Bottles) by Application (2021-2026)
Table 44. United States Open Angle Glaucoma Drugs Sales (K Bottles) by Company (2015-2020)
Table 45. United States Open Angle Glaucoma Drugs Sales Market Share by Company (2015-2020)
Table 46. United States Open Angle Glaucoma Drugs Sales (K Bottles) by Type (2015-2020)
Table 47. United States Open Angle Glaucoma Drugs Sales Market Share by Type (2015-2020)
Table 48. United States Open Angle Glaucoma Drugs Sales (K Bottles) by Application (2015-2020)
Table 49. United States Open Angle Glaucoma Drugs Sales Market Share by Application (2015-2020)
Table 50. Europe Open Angle Glaucoma Drugs Sales (K Bottles) by Company (2015-2020)
Table 51. Europe Open Angle Glaucoma Drugs Sales Market Share by Company (2015-2020)
Table 52. Europe Open Angle Glaucoma Drugs Sales (K Bottles) by Type (2015-2020)
Table 53. Europe Open Angle Glaucoma Drugs Sales Market Share by Type (2015-2020)
Table 54. Europe Open Angle Glaucoma Drugs Sales (K Bottles) by Application (2015-2020)
Table 55. Europe Open Angle Glaucoma Drugs Sales Market Share by Type (2015-2020)
Table 56. China Open Angle Glaucoma Drugs Sales (K Bottles) by Company (2015-2020)
Table 57. China Open Angle Glaucoma Drugs Sales Market Share by Company (2015-2020)
Table 58. China Open Angle Glaucoma Drugs Sales (K Bottles) by Type (2015-2020)
Table 59. China Open Angle Glaucoma Drugs Sales Market Share by Type (2015-2020)
Table 60. China Open Angle Glaucoma Drugs Sales (K Bottles) by Application (2015-2020)
Table 61. China Open Angle Glaucoma Drugs Sales Market Share by Application (2015-2020)
Table 62. Japan Open Angle Glaucoma Drugs Sales (K Bottles) by Company (2015-2020)
Table 63. Japan Open Angle Glaucoma Drugs Sales Market Share by Company (2015-2020)
Table 64. Japan Open Angle Glaucoma Drugs Sales (K Bottles) by Type (2015-2020)
Table 65. Japan Open Angle Glaucoma Drugs Sales Market Share by Type (2015-2020)
Table 66. Japan Open Angle Glaucoma Drugs Sales (K Bottles) by Application (2015-2020)
Table 67. Japan Open Angle Glaucoma Drugs Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Open Angle Glaucoma Drugs Sales (K Bottles) by Company (2015-2020)
Table 69. Southeast Asia Open Angle Glaucoma Drugs Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Open Angle Glaucoma Drugs Sales (K Bottles) by Type (2015-2020)
Table 71. Southeast Asia Open Angle Glaucoma Drugs Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Open Angle Glaucoma Drugs Sales (K Bottles) by Type (2015-2020)
Table 73. Southeast Asia Open Angle Glaucoma Drugs Sales Market Share by Application (2015-2020)
Table 74. India Open Angle Glaucoma Drugs Sales (K Bottles) by Company (2015-2020)
Table 75. India Open Angle Glaucoma Drugs Sales Market Share by Company (2015-2020)
Table 76. India Open Angle Glaucoma Drugs Sales (K Bottles) by Type (2015-2020)
Table 77. India Open Angle Glaucoma Drugs Sales Market Share by Type (2015-2020)
Table 78. India Open Angle Glaucoma Drugs Sales (K Bottles) by Application (2015-2020)
Table 79. India Open Angle Glaucoma Drugs Sales Market Share by Application (2015-2020)
Table 80. Merck Corporation Information
Table 81. Merck Description and Business Overview
Table 82. Merck Open Angle Glaucoma Drugs Sales (K Bottles), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 83. Merck Open Angle Glaucoma Drugs Product
Table 84. Merck Recent Development
Table 85. Allergan Corporation Information
Table 86. Allergan Description and Business Overview
Table 87. Allergan Open Angle Glaucoma Drugs Sales (K Bottles), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 88. Allergan Open Angle Glaucoma Drugs Product
Table 89. Allergan Recent Development
Table 90. Pfizer Corporation Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer Open Angle Glaucoma Drugs Sales (K Bottles), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 93. Pfizer Open Angle Glaucoma Drugs Product
Table 94. Pfizer Recent Development
Table 95. Novartis Corporation Information
Table 96. Novartis Description and Business Overview
Table 97. Novartis Open Angle Glaucoma Drugs Sales (K Bottles), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 98. Novartis Open Angle Glaucoma Drugs Product
Table 99. Novartis Recent Development
Table 100. Bausch Health Corporation Information
Table 101. Bausch Health Description and Business Overview
Table 102. Bausch Health Open Angle Glaucoma Drugs Sales (K Bottles), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 103. Bausch Health Open Angle Glaucoma Drugs Product
Table 104. Bausch Health Recent Development
Table . Santen Corporation Information
Table . Santen Description and Business Overview
Table . Santen Open Angle Glaucoma Drugs Sales (K Bottles), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2015-2020)
Table . Santen Open Angle Glaucoma Drugs Product
Table . Santen Recent Development
Table 110. Production Base and Market Concentration Rate of Raw Material
Table 111. Key Suppliers of Raw Materials
Table 112. Open Angle Glaucoma Drugs Distributors List
Table 113. Open Angle Glaucoma Drugs Customers List
Table 114. Market Key Trends
Table 115. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 116. Key Challenges
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Open Angle Glaucoma Drugs Product Picture
Figure 2. Global Open Angle Glaucoma Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Open Angle Glaucoma Drugs Market Share by Application in 2020 & 2026
Figure 6. Hospital Pharmacies Examples
Figure 7. Online Pharmacies Examples
Figure 8. Retail Pharmacies Examples
Figure 9. Global Open Angle Glaucoma Drugs Sales (K Bottles) Growth Rate (2015-2026)
Figure 10. Global Open Angle Glaucoma Drugs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Open Angle Glaucoma Drugs Price Trends Growth Rate (2015-2026) (USD/Bottle)
Figure 12. Global Open Angle Glaucoma Drugs Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Open Angle Glaucoma Drugs Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Open Angle Glaucoma Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Open Angle Glaucoma Drugs Sales (K Bottles) Growth Rate (2015-2026)
Figure 16. Europe Open Angle Glaucoma Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Open Angle Glaucoma Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Open Angle Glaucoma Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Open Angle Glaucoma Drugs Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Open Angle Glaucoma Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Open Angle Glaucoma Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Open Angle Glaucoma Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Open Angle Glaucoma Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Open Angle Glaucoma Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Open Angle Glaucoma Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Open Angle Glaucoma Drugs Players Market Share by Revenue in Open Angle Glaucoma Drugs 2015 & 2019
Figure 27. Open Angle Glaucoma Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Open Angle Glaucoma Drugs Revenue Share by Type (2015-2020)
Figure 29. Global Open Angle Glaucoma Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Open Angle Glaucoma Drugs Revenue Share by Application (2015-2020)
Figure 31. Global Open Angle Glaucoma Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Open Angle Glaucoma Drugs Sales Market Share by Type in 2019
Figure 33. United States Open Angle Glaucoma Drugs Sales Market Share by Type in 2019
Figure 34. Europe Open Angle Glaucoma Drugs Sales Market Share by Company in 2019
Figure 35. Europe Open Angle Glaucoma Drugs Sales Market Share by Type in 2019
Figure 36. Europe Open Angle Glaucoma Drugs Sales Market Share by Application in 2019
Figure 37. China Open Angle Glaucoma Drugs Sales Market Share by Company in 2019
Figure 38. China Open Angle Glaucoma Drugs Sales Market Share by Type in 2019
Figure 39. China Open Angle Glaucoma Drugs Sales Market Share by Application in 2019
Figure 40. Japan Open Angle Glaucoma Drugs Sales Market Share by Company in 2019
Figure 41. Japan Open Angle Glaucoma Drugs Sales Market Share by Type in 2019
Figure 42. Japan Open Angle Glaucoma Drugs Sales Market Share by Application in 2019
Figure 43. Southeast Asia Open Angle Glaucoma Drugs Sales Market Share by Company in 2019
Figure 44. Southeast Asia Open Angle Glaucoma Drugs Sales Market Share by Type in 2019
Figure 45. Southeast Asia Open Angle Glaucoma Drugs Sales Market Share by Application in 2019
Figure 46. India Open Angle Glaucoma Drugs Sales Market Share by Company in 2019
Figure 47. India Open Angle Glaucoma Drugs Sales Market Share by Type in 2019
Figure 48. India Open Angle Glaucoma Drugs Sales Market Share by Application in 2019
Figure 49. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Bausch Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Santen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Key Raw Materials Price Trend
Figure 56. Manufacturing Cost Structure of Open Angle Glaucoma Drugs
Figure 57. Manufacturing Process Analysis of Open Angle Glaucoma Drugs
Figure 58. Open Angle Glaucoma Drugs Industrial Chain Analysis
Figure 59. Channels of Distribution
Figure 60. Distributors Profiles
Figure 61. Porter's Five Forces Analysis
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed